Painful Diabetic Neuropathy
57
4
7
29
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
16 trials with published results (28%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
8.8%
5 terminated out of 57 trials
85.3%
-1.2% vs benchmark
12%
7 trials in Phase 3/4
55%
16 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 29 completed trials
Clinical Trials (57)
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy
EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA
EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy
Feasibility of Self-treatment of Painful Diabetic Neuropathy Using Electrical Vasomotor Nerve Stimulation
Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy -The HOPES Trial
BurstDR Stimulation for Painful Diabetic Neuropathy
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN
Multimodal Intervention for Painful Diabetic Neuropathy: NeuOst Feasibility Trial
Pain and Neurological Function Improvements With 10 kHz Spinal Cord Stimulation Treatment of Painful Diabetic Neuropathy
Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy
Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management
A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy
Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study
A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy
An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy